InvestorsHub Logo
Followers 18
Posts 4141
Boards Moderated 0
Alias Born 06/17/2006

Re: dianebRN post# 30660

Sunday, 05/02/2010 12:47:52 AM

Sunday, May 02, 2010 12:47:52 AM

Post# of 105534
No, BC/BS is not in the high road business but it will be cheaper for them to fund the transplant of stem cells than to transplant an entire heart, or treat long-term leukemia, Parkinson's, ALS, and a hundred other acute and chronic diseases.

Then, if the government (federal or state) gives them a few incentives........

Public/private partnerships, Red Cross, CBAI, insurance companies, teaching/research university hospitals with a leading-edge reputation to promote, countries like China wanting to steal the lead.........

After the damage to the reputation of the financial/banking system and the oil industry reputation currently up in flames in the Gulf, I would think the health care industry would want to pro-actively dodge that bullet.

Although, speaking of the health care industry, CBAI wants to be the stem cell pharma to the world. Do you know how much money the world-wide pharma industry pulls in every year??

Just re-define pharmaceuticals. Private stem cell storage the brand-names and public the generic. But patents only on the process, at least for now.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.